Moezzi Masoumeh, Imani Reza, Khosravi Nasser, Pourheidar Behrouz, Ganji Forouzan, Karimi Ali
Department of Community Medicine, Shahrekord University of Medical Sciences, Shahrekord, IR Iran.
Department of Infectious Diseases, Shahrekord University of Medical Sciences, Shahrekord, IR Iran.
Hepat Mon. 2014 May 3;14(5):e17398. doi: 10.5812/hepatmon.17389. eCollection 2014 May.
Hepatitis B virus is one of the important viral causes of liver inflammation with high worldwide prevalence and important hepatic and extra hepatic complications.
The aim of this study was to investigate the prevalence and risk factors of hepatitis B in Chaharmahal and Bakhtiari province, Iran.
For this descriptive, analytical, population-based study, 3000 participants older than 15 years were enrolled according to the clustering method. After obtaining written informed consent and taking required blood samples, we gathered data on demographic status and probable transmission routes of disease using questionnaire between 2012 and 2013. The data was analyzed using SPSS software (descriptive parameters and chi-square). P value below 0.05 was considered as statistically significant.
The mean age of participants was 38.4 ± 16.3. The seroprevalence rate of hepatitis B was found to be 1.3% (95% CI, 0.95%-1.81%). Prevalence of HBeAg among HBsAg positive participants was 2.5% (only 1 of 40). Seroprevalence was higher in male group (2.5 times higher than women), age group of over 55 years, farmers, and non-public occupations. Positive seroprevalence was associated with a history of renal disease, familial transmission, transfusion, surgery in hospital, circumcision, contact with hepatitis B infected individuals, imprisonment, intravenous (IV) drug abuse, and smoking (P < 0.05). Nevertheless, the highest odds ratio (OR) was obtained for history of renal disease (OR = 7.64: 3.01-18.4), followed by imprisonment (OR = 5.4: 1.86 -15.7) and IV drug abuse (OR = 5.68: 1.3-24.7).
Chaharmahal and Bakhtiari province could be categorized as a low endemic region for hepatitis B infection, with a seroprevalence similar to that in other provinces of western Iran. Vaccination seems to influence its decrease, especially in adolescents and youth. More surveillance and attention to risk factors are suggested to identify high-risk groups and to implement vaccination.
乙型肝炎病毒是导致肝脏炎症的重要病毒之一,在全球范围内具有较高的流行率,并会引发重要的肝脏及肝外并发症。
本研究旨在调查伊朗恰哈马哈勒-巴赫蒂亚里省乙型肝炎的流行率及危险因素。
在这项基于人群的描述性分析研究中,采用整群抽样法纳入了3000名15岁以上的参与者。在获得书面知情同意并采集所需血样后,我们于2012年至2013年期间通过问卷调查收集了人口统计学状况及可能的疾病传播途径的数据。使用SPSS软件(描述性参数和卡方检验)对数据进行分析。P值低于0.05被视为具有统计学意义。
参与者的平均年龄为38.4±16.3岁。乙型肝炎的血清流行率为1.3%(95%可信区间,0.95%-1.81%)。在乙肝表面抗原(HBsAg)阳性参与者中,e抗原(HBeAg)的流行率为2.5%(40例中仅1例)。男性组的血清流行率更高(比女性高2.5倍),55岁以上年龄组、农民及非公职职业人群的血清流行率也较高。血清阳性率与肾病病史、家族传播、输血、住院手术、包皮环切术、与乙肝感染者接触、监禁、静脉注射吸毒及吸烟相关(P<0.05)。然而,肾病病史的比值比(OR)最高(OR=7.64:3.01-18.4),其次是监禁(OR=5.4:1.86-15.7)和静脉注射吸毒(OR=5.68:1.3-24.7)。
恰哈马哈勒-巴赫蒂亚里省可被归类为乙型肝炎感染的低流行地区,其血清流行率与伊朗西部其他省份相似。疫苗接种似乎对其感染率的下降有影响,尤其是在青少年和青年中。建议加强监测并关注危险因素,以识别高危人群并实施疫苗接种。